Fate Therapeutics, Inc.FATENASDAQ
Loading
Year-over-year debt growth rate
Percentile
P31
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -1.76% |
| Q3 2025 | -2.56% |
| Q2 2025 | -2.40% |
| Q1 2025 | -2.27% |
| Q4 2024 | -13.85% |
| Q3 2024 | -1.58% |
| Q2 2024 | -1.48% |
| Q1 2024 | -1.42% |
| Q4 2023 | -1.35% |
| Q3 2023 | -1.31% |
| Q2 2023 | -1.18% |
| Q1 2023 | -1.58% |
| Q4 2022 | -1.43% |
| Q3 2022 | -1.23% |
| Q2 2022 | -1.07% |
| Q1 2022 | -1.13% |
| Q4 2021 | 5.28% |
| Q3 2021 | -1.28% |
| Q2 2021 | -0.41% |
| Q1 2021 | 14.00% |
| Q4 2020 | 13.82% |
| Q3 2020 | 5.49% |
| Q2 2020 | 7.01% |
| Q1 2020 | 181.25% |
| Q4 2019 | -34.70% |
| Q3 2019 | -3.17% |
| Q2 2019 | -0.07% |
| Q1 2019 | 186.32% |
| Q4 2018 | 0.13% |
| Q3 2018 | 0.13% |
| Q2 2018 | 0.13% |
| Q1 2018 | 0.13% |
| Q4 2017 | 0.13% |
| Q3 2017 | 121.52% |
| Q2 2017 | -23.27% |
| Q1 2017 | -18.59% |
| Q4 2016 | -15.41% |
| Q3 2016 | -13.10% |
| Q2 2016 | -11.37% |
| Q1 2016 | -10.05% |